Partnership / Collaboration · MENA · Announced 18 Nov 2026
Eva Pharma → Med Right
EVA Pharma signed a cooperation protocol with Egyptian healthcare programme manager Med Right to extend its patient support programmes in cardiometabolic, immunology, oncology, and bone and pain to Med Right's network beneficiaries in Egypt.
Parties: EVA Pharma (Egypt) → Med Right (Egypt)
- Deal type
- Partnership / Collaboration
- Value
- Undisclosed
- Territory
- Egypt
- Therapeutic area
- Multi-therapy
- Asset
- Patient support programmes
- Announced
- 18 Nov 2026
Our analysis
Why this matters
EVA Pharma and Med Right for Healthcare Program Management announced on 18 November 2026, from Cairo, a cooperation protocol that extends EVA Pharma's patient support programmes (PSPs) to beneficiaries of Med Right's network. The programmes cover cardiometabolic health, immunology, oncology, and bone health and pain management. No financial terms were disclosed.
The protocol also includes continuing medical education and training for physicians and Med Right's case-management teams. Patients already enrolled stay on a programme until the end of their current course of treatment, even if the arrangement is terminated. The parties say they may later look at wellness programmes.
The full analysis is free to read with a work email on this page.
Source: Dawaa News MENA